Working... Menu

Phase 1 Study of BXQ-350 in Adult Patients With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02859857
Recruitment Status : Recruiting
First Posted : August 9, 2016
Last Update Posted : January 23, 2019
CTI Clinical Trial and Consulting Services
Information provided by (Responsible Party):
Bexion Pharmaceuticals, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : November 2019
  Estimated Study Completion Date : January 2020